ARTICLE | Clinical News
Berlex Laboratories regulatory update
May 15, 1995 7:00 AM UTC
Berlex's Ultravist (iopromide) injection received FDA approval as a nonionic contrast agent for x-ray imaging. The Wayne, N.J., company said Ultravisc, which is sold in 78 countries, will be available...